SE433494B - Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat - Google Patents

Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat

Info

Publication number
SE433494B
SE433494B SE7701552A SE7701552A SE433494B SE 433494 B SE433494 B SE 433494B SE 7701552 A SE7701552 A SE 7701552A SE 7701552 A SE7701552 A SE 7701552A SE 433494 B SE433494 B SE 433494B
Authority
SE
Sweden
Prior art keywords
pyrimidin
derivatives
analogy procedure
tetrazolyl
preparing
Prior art date
Application number
SE7701552A
Other languages
English (en)
Swedish (sv)
Other versions
SE7701552L (sv
Inventor
P F Juby
R A Partyka
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/748,851 external-priority patent/US4082751A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7701552L publication Critical patent/SE7701552L/xx
Publication of SE433494B publication Critical patent/SE433494B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7701552A 1976-02-13 1977-02-11 Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat SE433494B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65778776A 1976-02-13 1976-02-13
US05/748,851 US4082751A (en) 1976-02-13 1976-12-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
SE7701552L SE7701552L (sv) 1977-09-23
SE433494B true SE433494B (sv) 1984-05-28

Family

ID=27097492

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701552A SE433494B (sv) 1976-02-13 1977-02-11 Analogiforfarande for framstellning av tetrazolyl-pyrimidin-4-on-derivat

Country Status (14)

Country Link
JP (1) JPS52118481A (da)
AU (1) AU508970B2 (da)
CA (1) CA1083152A (da)
CH (1) CH635339A5 (da)
DE (1) DE2705609A1 (da)
DK (1) DK149044C (da)
FI (1) FI62533C (da)
FR (1) FR2340943A1 (da)
GB (1) GB1541351A (da)
IE (1) IE44603B1 (da)
LU (1) LU76722A1 (da)
NL (1) NL173055C (da)
SE (1) SE433494B (da)
YU (1) YU41567B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419357A (en) * 1982-01-18 1983-12-06 The Dow Chemical Company 3-(1H-Tetrazol-5-yl)-4(3H)-quinazolinones
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883653A (en) * 1972-10-24 1975-05-13 Pfizer Method of preventing asthmatic symptoms

Also Published As

Publication number Publication date
JPS52118481A (en) 1977-10-04
FI62533C (fi) 1983-01-10
FR2340943A1 (fr) 1977-09-09
NL173055C (nl) 1983-12-01
DE2705609A1 (de) 1977-08-25
FI62533B (fi) 1982-09-30
AU508970B2 (en) 1980-04-17
IE44603B1 (en) 1982-01-27
FI770427A (da) 1977-08-14
YU35477A (en) 1982-10-31
AU2189577A (en) 1978-08-10
YU41567B (en) 1987-10-31
DE2705609C2 (da) 1988-12-15
LU76722A1 (da) 1977-08-18
DK57377A (da) 1977-08-14
FR2340943B1 (da) 1981-01-09
NL7701483A (nl) 1977-08-16
DK149044B (da) 1985-12-30
CA1083152A (en) 1980-08-05
IE44603L (en) 1977-08-13
NL173055B (nl) 1983-07-01
SE7701552L (sv) 1977-09-23
JPS6139947B2 (da) 1986-09-06
GB1541351A (en) 1979-02-28
DK149044C (da) 1986-06-02
CH635339A5 (en) 1983-03-31

Similar Documents

Publication Publication Date Title
SE440791B (sv) Forfarande for upparbetning av lignitkol
SE446740B (sv) Forfarande for framstellning av muramyldipeptidderivat
NO782768L (no) Fremgangsmaate for fremstilling av alkenderivater
SE440501B (sv) Forfarande for framstellning av substituerade fenylamidoximer
RO76589A (ro) Procedeu pentru prepararea alchilaminelor heterociclice
SE432595B (sv) Analogiforfarande for framstellning av piperidyl-indolderivat
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE440772B (sv) Forfarande for framstellning av nya 1-naftylmetyl-cinnamyl-aminderivat
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
SE438856B (sv) Analogiforfarande for framstellning av 1-acyloximetyl-3-fluoruracilderivat
SE433212B (sv) Forfarande for framstellning av 4-hydroxi-aporfin-derivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE7704139L (sv) Forfarande for framstellning av azofergemnen
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE433219B (sv) Forfarande for framstellning av 3-halogenmetylcefalosporinforeningar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE443140B (sv) Forfarande for framstellning av karbostyrilderivat
SE431336B (sv) Analogiforfarande for framstellning av substituerade 8-azapurinderivat
SE433220B (sv) Forfarande for framstellning av nya pregnan-derivat
SE439631B (sv) Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO773073L (no) Fremgangsmaate for fremstilling av 2-piperazinyl-kinazolinderivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7701552-7

Effective date: 19920904

Format of ref document f/p: F